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Background: Senescence of the neurons is believed to be a focal factor in the development of age-related
neurodegenerative diseases such as Alzheimer’s disease. Diminutions in the levels of nerve growth factor (NGF) lead
to major declines in brain cell performance. Functional foods, believed to mitigate this deficiency, will be reaching a
plateau in the near future market of alternative and preventive medicine. In the search for neuroactive compounds
that mimic the NGF activity for the prevention of neurodegenerative diseases, the potential medicinal values of
culinary and medicinal mushrooms attract intense interest.
Methods: Cytotoxic effects of aqueous extracts of three medicinal mushrooms basidiocarps, Ganoderma lucidum,
Ganoderma neo-japonicum and Grifola frondosa towards rat pheochromocytoma (PC-12) cells were determined by
3-(4,5-dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The potentiation of neuritogenic activity
was assessed by neurite outgrowth stimulation assay. Involvement of cellular signaling pathways, mitogen-activated
protein kinase kinase/extracellular signal-regulated kinase (MEK/ERK1/2) and phosphoinositide-3-kinase/protein
kinase B (PI3K/Akt) in mushrooms-stimulated neuritogenesis were examined by using specific pharmacological
inhibitors. Alteration of neuronal morphology by inhibitors was visualized by immunofluorescence staining of the
neurofilament.
Results: All the aqueous extracts tested caused a marked stimulation of neuritogenesis with no detectable
cytotoxic effects towards PC-12 cells. The aqueous extract of G. neo-japonicum triggered maximal stimulation of
neurite outgrowth at a lower concentration (50 μg/ml) with 14.22 ± 0.43% of neurite-bearing cells, compared to G.
lucidum and G. frondosa that act at a higher concentration (75 μg/ml), with 12.61 ± 0.11% and 12.07 ± 0.46% of
neurite-bearing cells, respectively. The activation of MEK/ERK1/2 and PI3K/Akt signaling pathways were necessary for
the NGF and aqueous extracts to promote neuritogenesis.
Conclusions: Ganoderma lucidum, G. neo-japonicum and G. frondosa may contain NGF-like bioactive compound(s)
for maintaining and regenerating the neuronal communications network. The present study reports the first
evidence of the neuritogenic effects of aqueous extracts of basidiocarps of G. neo-japonicum in-vitro and showed
the involvement of MEK/ERK1/2 and P13K/Akt signaling pathways for neuritogenesis in PC-12 cells.
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According to the World Health Organization (WHO),
nearly 35.6 million people worldwide live with dementia in
2010. The number is expected to double by 2030 (65.7 mil-
lion) and more than triple by 2050 (115.4 million) [1].
Dementia is a brain function syndrome characterized by a
cluster of symptoms and signs manifested by difficulties in
memory, disturbances in language, psychological and psy-
chiatric changes, and impairments in activities of daily living.
Alzheimer's disease is one form of dementia that gradually
gets worse over time. It affects memory, thinking, and
behaviour [2].
Neuritogenic activity is one of the focuses of the study
on the preventive and therapeutic effects of neurodegen-
erative diseases. Neuritogenic substances hold the prom-
ise of therapeutic efficacy in the treatment of neuronal
injuries by the virtue of their ability to stimulate out-
growth of neurites from neuronal cells [3]. Recent re-
ports showed that many extracts or compounds from
natural sources possessed significant neuritogenic activ-
ity in vitro and in vivo, included hericenones and
erinacines from Hericium erinaceus (lion’s mane mush-
room) [4] and curcumin from Curcuma longa [5].
Nerve growth factor has potent biological activities
such as promoting neuronal survival and neuritogenesis
[6]. It is targeted as a potential therapeutic drug for the
treatment of neurodegenerative disorders [7,8]. However,
NGF is unstable and is unable to cross blood–brain bar-
rier because of its high molecular polypeptide [9].
Hence, the potential medicinal values of culinary and
medicinal mushrooms have attracted intense interest in
the search for pharmacological compounds that mimic
the NGF activity in the prevention of neurodegenerative
diseases. Medicinal mushrooms have a long and rich his-
tory of use as mycomedicinals [10,11]. Extracts of medi-
cinal mushrooms have long been an important part of
traditional oriental medicines. Many studies reported
that edible and medicinal mushrooms possessed
neuritogenic effects. In the previous studies, the
neuritogenic and nerve regeneration effects of Hericium
erinaceus (Bull.:Fr.) Pers. in in vitro and in vivo [12-14],
the sclerotium of Lignosus rhinocerotis (Cooke) Ryvarden
(tiger’s milk mushroom) [15] and Pleurotus giganteus
(Berk.) Karunarathna & K.D. Hyde (morning glory
mushroom) [16] were documented.
The genus Ganoderma is a popular medicinal mushroom,
and is used in traditional Chinese medicine (TCM) as a
tonic and sedative in Asian countries. For over two millen-
nia its use is documented in countries including China,
Japan and Korea [17,18]. Ganoderma lucidum (Curtis: Fr.)
P. Karst, called “Lingzhi” in Chinese and “Reishi” in
Japanese, is one of the most commonly used mushroom by
TCM in Asia [17]. According to “Shennong Ben Cao Jing”,
a Chinese book on agriculture and medicinal plants (300BC – 200 AC), Lingzhi is classified into six categories based
on colour, which are red, yellow, black, white, green and
purple. Ganoderma lucidum is the most common red
Lingzhi and Ganoderma neo-japonicum Imazeki is catego-
rized as purple Lingzhi. Ganoderma neo-japonicum is
found in Mainland China, Japan and Taiwan, and grows
saprotrophically on dead hardwoods or bamboos [19]. In
Malaysia, G. neo-japonicum grows on bamboo. A water in-
fusion is used by the indigenous folks as medicine and a
tonic to strengthen the body (unpublished data). Grifola
frondosa (Dicks.) Gray, also known by its Japanese name
“Maitake” which means “dancing mushroom”, has been
used as a health food for centuries in China and Japan.
Maitake is a delicious culinary mushroom and also valued
for its medicinal properties. Studies have shown that G.
lucidum [18] and G. frondosa [20] possessed neuritogenic
effects in preventing and treating neurological disorders.
However, no information is available on the neuronal ef-
fects of G. neo-japonicum.
The present work reports the study of neuritogenic ef-
fects of aqueous extracts of medicinal mushrooms basidio-
carps, namely H. erinaceus, G. lucidum, G. neo-japonicum
and G. frondosa on PC-12 cells. Furthermore, the effects of
cellular signaling pathways, MEK/ERK1/2 and PI3K/Akt in
the potentiation of neuritogenic activity in PC-12 cells by
using specific pharmacological inhibitors were investigated.
Methods
Materials and chemicals
The H. erinaceus (KLU-M 1232) and G. lucidum (KLU-
M 1233) basidiocarps were obtained from Ganofarm in
Tanjung Sepat, Selangor. Ganoderma neo-japonicum
(KLU-M 1231) basidiocarps were collected from a forest
in Ulu Grik, Perak and G. frondosa basidiocarps (KLU-
M 1229) were purchased from a hypermarket in
Selangor, Malaysia. The mushrooms were identified and
authenticated by experts in the Mushroom Research
Centre, University of Malaya. Voucher specimens are de-
posited in the University of Malaya herbarium (KLU-M).
Rat pheochromocytoma (PC-12Adh) cell line was pur-
chased from American Type Culture Collection (ATCC;
Rockville, MD, USA; Catalogue Number: CRL-1721.1).
Kaighn’s Modification of Ham’s F-12 Medium (F-12 K
medium), NGF-7S from murine submaxillary gland, 3-
(4,5-dimethythiazol-2-yl)-2,5-diphenyltetrazolium brom-
ide (MTT), phosphate buffered saline (PBS), dimethyl
sulfoxide (DMSO), MEK inhibitor (U0126, PD98059),
PI3K inhibitor (LY294002), anti-neurofilament 200 (NF-
200) antibody produced in rabbit and Anti-Rabbit IgG-
Fluorescein isothiocyanate (FITC) antibody produced in
sheep were obtained from Sigma Co. (St. Louis, MO,
USA). ProLong® Gold Antifade Reagent with DAPI (4-6-
Diamidino-2-phenylindole) was purchased from Life
Technologies Corporation (California, USA). Fetal
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chased from PAA Laboratories (Cölbe, Germany).
Preparation of aqueous extracts
The aqueous extracts were prepared according to Eik
et al. [15]. Briefly, the fresh basidiocarps of H.
erinaceus and G. frondosa were sliced, weighed and
freeze-dried while G. lucidum and G. neo-japonicum
were air dried. The dried basidiocarps were then
ground into powder by a Waring commercial blender.
The powder was then soaked in distilled water at a
ratio of 1:20 (w/v) and 150 rpm at room temperature.
After 24 h, the mixture was double boiled in a water
bath for 30 min and after cooling was filtered
through Whatman no. 4 filter paper. The resulting
aqueous extracts were freeze-dried and kept at −20°C
prior to use.
In vitro cell culture
The rat pheochromocytoma (PC-12Adh) cells were
sustained in ATCC formulated F-12 K medium and
supplemented with 15% (v/v) of heat-inactivated HS and
2.5% (v/v) of heat-inactivated FBS with final pH 6.8 -
7.2. The cells were subcultured every 2 to 3 days and in-
cubated at 37 ± 2°C in a 5% CO2-humidified incubator.
Cell viability and cytotoxicity assay
Cell viability was assessed by the mitochondrial-
dependent reduction of MTT to purple formazan.
PC-12 cells were plated in 96-well plates at a density
of 5 × 103 cells/well and incubated overnight at 37°C
in a 5% CO2-humidified incubator. Then, the aqueous
extracts (0–2500 μg/ml) were added into the cells.
After 48 h of incubation, 20 μl of MTT (5 mg/ml) in
PBS buffer (pH 7.4) was added into each well and in-
cubated at 37°C for 4 h. Subsequently, the super-
natant was carefully discarded by aspiration, and
100 μl of DMSO was then added into each well to
dissolve the MTT formazan crystals, mixed thor-
oughly and incubated for 15 min. The extent of the
reduction of MTT was determined by measurement
of the absorbance at 540 nm with 690 nm as back-
ground absorbance with an ELISA microplate reader
(Sunrise, Tecan, Austria). The complete F-12 K
medium was the blank, and cells incubated in the
medium only were denoted as the negative control.
Neurite outgrowth stimulation assay
Cells were plated in 12-well plates at a density of 5 × 103
cells per well in complete F-12 K medium. The cells
were treated with freshly prepared aqueous extracts at
various concentrations ranged from 25 to 100 μg/ml
(w/v). Eik et al. [15] reported that 50 ng/ml (w/v) of
NGF-7S from murine submaxillary gland was theoptimum concentration for neuritogenesis in PC-12
cells. In the present study, cells treated with 50 ng/ml
(w/v) of NGF or 50 μg/ml (w/v) of H. erinaceus served
as positive controls. Cells in complete F-12 K medium
without treatment served as a negative control. Assay
plates were incubated for 48 h at 37 ± 2°C in a 5% CO2-
humidified incubator.
Quantification of neurite outgrowth
The cell morphology was assessed under an inverted micro-
scope (Nikon Eclipse TS100). Neurite extension of PC-12
cells was regarded as an index of neuritogenesis. Neurite
that was double or more the length of the cell body diam-
eter was scored positive for a neurite-bearing cell [14]. The
images were captured with a QImaging Go-3 color CMOS
Camera (QImaging, Canada) and by the image processor
system, Image-Pro Insight (MediaCybernetics, MD). The
percentage of differentiated cells was evaluated by scoring
the proportion of neurite-positive cells to total cells in ran-
domly 10 selected microscopic fields per well, with an aver-
age of 200–300 cells per well.
Treatment with specific inhibitors of signaling pathways
The MEK/ERK1/2 inhibitors (U0126, PD98059) and
PI3K/Akt inhibitor (LY294002) were used in this
study. Stock solutions (10 mM) of inhibitors were
prepared in DMSO and stored at −20°C in the dark.
Final concentrations of 10 μM of U0126, 30 μM of
LY294002 and 40 μM of PD98059 were prepared by
diluting in complete F-12 K medium just before use
[16]. Cells were pre-incubated either with or without
the inhibitor for 1 h at 37 ± 2°C in a 5% CO2-humidi-
fied incubator, respectively before the treatment with
50 ng/ml (w/v) of NGF or the optimum concentration
of each aqueous extract resulting in the neurite out-
growth stimulation assay. Cells were then incubated
for 48 h prior to scoring the neurite-bearing cells.
Immunofluorescence staining of neurofilament
Immunofluorescence assay was carried out according
to Schimmelpfeng et al. [21] with some modifications.
Briefly, cells were seeded in 12-well micro-chamber
(ibidi, Martinsried, Germany) at a density of 5 × 103
cells per well in complete F-12 K medium. Then, the
cells were pre-incubated either with or without the
treatment of inhibitors. After 1 h, the cells were
treated with the optimum concentration of each aque-
ous extract result in the neurite outgrowth stimula-
tion assay for 48 h at 37 ± 2°C in a 5% CO2-
humidified incubator. Subsequently, the cells were
fixed with 4% formalin (v/v) at room temperature for
20 min. After three washings with PBS, the cells were
incubated with anti-NF-200 antibody produced in
rabbit (1:80 dilution in blocking buffer) at room
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with fluorophore-conjugated secondary antibody, anti-
Rabbit IgG-FITC antibody produced in sheep (1:80
dilution in blocking buffer) at room temperature for
1 h in the dark. Cells were mounted with aqueous
mounting medium, ProLong® Gold Antifade Reagent
with DAPI. Slides were observed under fluorescence
illumination using FITC and DAPI filters and images
were captured with Nikon’s Imaging Software, NIS-
Elements.Statistical analysis
All the experimental data were expressed as the mean ±
standard deviation (SD). Statistical differences between
groups were performed using one-way analysis of variance
(ANOVA) of a minimum of three independent experiments
and Duncan's multiple range tests (DMRT) P < 0.05 was












































































Figure 1 Effects of aqueous extracts on the cell viability of PC-12 cell
from 0 to 2500 μg/ml for 48 h. (a) Ganoderma lucidum, (c) Ganoderma neo
from the intercept on the x-axis (y = 0) of the regression line using the line
absorbance was obtained using complete F-12 K medium with cells only w
(n = 3). * p < 0.05 compared to the respective control 100%.Results
The cells viability and cytotoxic effects of aqueous
extracts on PC-12 cells
All aqueous extracts tested did not exert any detectable
cytotoxic effect in PC-12 cells. The survival rates of the
cells were decreased in a concentration-dependent
manner, G. lucidum (Figure 1a,b), G. neo-japonicum
(Figure 1c,d), and G. frondosa (Figure 1e,f). The negative
control, cells in complete F-12 K medium only, was con-
sidered as 100% of cell viability. A significant (p < 0.05)
stimulation of proliferation was observed at the concen-
tration of 7.81 μg/ml and 15.63 μg/ml of G. neo-
japonicum. The cell viability was significantly (p < 0.05)
decreased at the concentration of 62.5 ug/ml (G.
lucidum), 250 ug/ml (G. neo-japonicum) and 31.25
ug/ml (G. frondosa) with the percentage inhibitions
of 13.41%, 16.57% and 13.85%, respectively, compared
to the negative control. The reduction in the cell
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Figure 2 Effects of aqueous extracts on the neuritogenic activity of PC-12 cells. The percentage of neurite-bearing cells of PC-12 cells
treated with various concentrations of aqueous extracts ranged from 25 to 100 μg/ml. Cells in complete F-12 K medium without treatment
served as a negative control. Cells treated with 50 ng/ml of NGF or 50 μg/ml of H. erinaceus (HE) served as positive controls. Data were expressed
as means ± standard deviation (n = 3). Means with different alphabets shows significant difference p < 0.05. *** p < 0.001 compared to NGF.
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tion to inhibit the cell growth by 50% (IC50) for
aqueous extracts of G. lucidum, G. neo-japonicum
and G. frondosa were 1298.71 ug/ml, 3037.32 ug/ml
and 4384.68 ug/ml, respectively.
The neuritogenic effect of aqueous extracts on PC-12 cells
All concentrations of aqueous extracts tested
showed neuritogenic effects after 48 h of incubation
(Figure 2). Nerve growth factor- and H. erinaceus-
treated cells served as positive controls. The per-
centage of neurite-bearing cells of G. lucidum-, G.
neo-japonicum- and G. frondosa- treated cells were
significantly (p < 0.05) increased in a concentration-





































Figure 3 Effects of the specific inhibitors of MEK/ERK1/2 and PI3K on
exposed to U0126, PD98059 and LY294002 for 1 h before the treatment of
frondosa (GF). Cells in complete F-12 K medium without treatment served
of H. erinaceus (HE) served as positive controls. A control without inhibitor
standard deviation (n = 3). *** p < 0.001 compared to respective controls.0.05) between the negative control and all concentrations of
aqueous extracts tested. Interestingly, the percentage of
neurite-bearing cells of aqueous extract of G. neo-japonicum
at 50 μg/ml (14.22 ± 0.43%) was significantly higher (p < 0.05)
compared to NGF and was comparable to neurite outgrowth
stimulation by H. erinaceus (14.66 ± 0.5%). Maximum stimu-
lation of neuritogenesis by aqueous extract of G. neo-
japonicum was achieved at 50 μg/ml with 14.22% of neurite-
bearing cells, followed by G. lucidum (12.61%) and G.
frondosa (12.07%) at a higher concentration of 75 μg/ml.
There was no significant difference in the percent-
age of neurite-bearing cells between 50 ng/ml of
NGF (11.94 ± 0.38%) and 75 μg/ml of aqueous ex-
tract of G. lucidum (12.61 ± 0.11%) and G. frondosa












aqueous extracts-stimulated neuritogenesis. PC-12 cells were
aqueous extracts of G. lucidum (GL), G. neo-japonicum (GNJ) and G.
as a negative control. Cells treated with 50 ng/ml of NGF or 50 μg/ml
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Figure 4 Morphology of PC-12 cells in different treatment groups. PC-12 cells were exposed to U0126 (10 μM), PD98059 (40 μM) and
LY294002 (30 μM) for 1 h before the treatment of aqueous extracts. (a) to (d) negative control (complete F-12 K medium), (e) to (h) positive
control (NGF; 50 ng/ml), (i) to (l) positive control (H. erinaceus (HE); 50 μg/ml), (m) to (p) 75 μg/ml of G. lucidum (GL), (q) to (t) 50 μg/ml of G.
neo-japonicum (GNJ), (u) to (x) 75 μg/ml of G. frondosa (GF). Nuclei stained blue and neurofilaments stained green. Scale bars represent 50 μM.
Arrows indicate neurite outgrowth.
Ling-Sing Seow et al. BMC Complementary and Alternative Medicine 2013, 13:157 Page 6 of 10
http://www.biomedcentral.com/1472-6882/13/157The involvement of MEK/ERK1/2 and PI3K/Akt signaling
pathways in aqueous extracts-stimulated neuritogenesis
The MEK/ERK1/2 inhibitors, U0126 (10 μM) and
PD98059 (40 μM) blocked the neuritogenic activity of
aqueous extracts and NGF (Figure 3). The results
showed that PD98059 decreased the percentage of
neurite-bearing cells by approximately 90.16% in G.
lucidum, 76.42% in G. neo-japonicum and 89.73% in G.
frondosa treated cells compared to each individual con-
trol. In the presence of PI3K/Akt inhibitor, LY294002
(30 μM), the number of neurite-bearing cells were
decreased significantly (p < 0.001). The significant (p <
0.001) reduction of neurite stimulation activities werealso observed in the negative control-, NGF- and aque-
ous extracts of H. erinaceus- stimulated neuritogenesis with
the addition of the inhibitors. These data suggest that activa-
tion of MEK/ERK1/2 and PI3K/Akt signaling pathways are
involved in aqueous extracts-stimulated neuritogenesis in
PC-12 cells.
The effect of MEK/ERK1/2 and PI3K/Akt inhibitors on
neuronal morphology visualized by immunofluorescence
staining
To examine the pattern of neuritogenesis further, PC-
12 cells were stained by immunofluorescence dyes in-
corporated with anti-NF-200 antibody. PC-12 cells












Figure 5 Hypothetic mechanisms of NGF and mushroom aqueous extracts in promoting neuritogenesis in PC-12 cells. Both nerve
growth factor and aqueous extracts bind to tyrosine receptor, TrkA and initiate two major signaling pathways, the MEK/ERK1/2 and PI3K/Akt
pathways. Activation of MEK/ERK1/2 and PI3K/Akt cascade promotes neuritogenesis of PC-12 cells. In the present study, the MEK/ERK1/2 inhibitors
(U0126, PD98059) and PI3K/Akt inhibitor (LY294002) blocked the neuritogenic activity of NGF and aqueous extracts. Therefore, based on the present
findings, the activation of MEK/ERK1/2 and PI3K/Akt signaling pathways are needed for the NGF and aqueous extracts in promoting neuritogenesis.
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were stained green by anti-NF-200 labeled with FITC.
The cells were pre-treated, with or without specific
inhibitors, prior to the addition of the aqueous ex-
tracts and incubated for 48 h. In the negative control,
the cells are relatively small and rounded with few
visible neurites (Figure 4a). With the treatment of
50 ng/ml of NGF, 50 μg/ml of H. erinaceus, 75 μg/ml
of G. lucidum, 50 μg/ml of G. neo-japonicum and
75 μg/ml of G. frondosa, the cells were larger and
elongated. Cells also exhibited neurite extensions that
were double the length of the cell body diameter
(Figure 4e, 4i, 4m, 4q, 4u). However, some morpho-
logical changes in neuronal differentiation were
observed in the treatment of U0126, PD98059 and
LY294002 inhibitors. The inhibitors blocked the
neuritogenic activity of aqueous extracts and NGF
and caused shrunken and rounded cell bodies without
noticeable neurite extension. These results suggest
that the activation of MEK/ERK1/2 and PI3K/Akt sig-
naling pathways are needed for the NGF and aqueous
extracts in promoting neuritogenesis.
Discussion
In the present study, PC-12Adh cell line was utilized as
a model system to investigate the cytotoxicity,
neuritogenic activity and elucidate the underlying mech-
anisms of aqueous extracts of medicinal mushroomsbasidiocarps, namely G. lucidum, G. neo-japonicum and
G. frondosa. The PC-12 cell line is established from rat
adrenal pheochromocytoma (adrenal medullary tumour)
[22] and has been extensively used as a model to investi-
gate the neuronal differentiation, proliferation and sur-
vival [23]. With the addition of NGF, PC-12 cells are
able to differentiate into sympathetic neuron-like pheno-
types characterized by neurite outgrowth and the ex-
pression of several neuron-specific proteins [22,24].
Nerve growth factor is crucial for the survival, develop-
mental and differentiation of the central and peripheral
neurons [25,26]. The neurotrophic effect of NGF is trans-
duced by high affinity tyrosine receptor TrkA [27], the
NGF receptor, and then it activates several signaling path-
ways via intracellular signaling molecules that include Ras
[28], PI3K [26,29], ERK [30] and p38 MAPK [31].
Aqueous extraction has been the most commonly used
method for the isolation of bioactive polysaccharides
from mushrooms such as glucans [10,32]. According to
Cheung et al. [18], the extract of Ganoderma contained
polysaccharides that possessed neuroactivity. It had been
reported that crude aqueous extract of Tremella fuciformis
(white jelly mushroom) possessed neuritogenic effects
in vitro and anti-amnesic effects in vivo [33]. According to
Lin et al. [34], treatment with the water extract of G.
lucidum and G. neo-japonicum showed antioxidant effect
on free radical scavenging activity and hepatoprotective ef-
fect against CCl4-induced liver injury. Aqueous extraction is
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the organic solvent. In this study, medicinal mushrooms
were extracted by water, in conjunction with the traditional
use of mushrooms as part of TCM. In addition, water is
non-toxic to cells. From data obtained in this study, the IC50
value of cytotoxic activity of G. lucidum, G. neo-japonicum
and G. frondosa were approximately 17-, 60- and 58- fold
higher than their optimum concentration that stimulated
neuritogenesis. Further, the results indicated that the aque-
ous extracts of all tested mushrooms were not cytotoxic to
PC-12 cells.
The results suggested that all aqueous extracts tested
caused a marked stimulation of neuritogenesis in PC-
12 cells and they appeared to be comparably active with
the neuritogenic effects in vitro of NGF. Therefore, the
aqueous extracts of G. lucidum, G. neo-japonicum and
G. frondosa may possess NGF-like bioactive com-
pounds that mimic the neuroactivity of NGF for neur-
onal survival, development and differentiation. The
aqueous extract of G. neo-japonicum triggered maximal
stimulation of neuritogenesis at a lower concentration
compared to G. lucidum and G. frondosa that act at a
higher concentration. Neuritogenic activity of higher
basidiomycetes other than G. neo-japonicum, G.
lucidum and G. frondosa has also been reported. These
included H. erinaceus [4,35], Sarcodon scabrosus [36],
Sarcodon cyrneus [37,38], Termitomyces albuminosus
[39,40] and Cordyceps militaris [41]. Shi et al. [36] reported
that cyathane diterpenoids isolated from S. scabrosus
showed significant neuritogenic activity in combination
with 20 ng/mL of NGF in PC-12 cells after 24 h treatment.
The extract of C. militaris stimulated neuritogenesis, en-
hanced neuronal functions of Neuro2A mouse neuroblast-
oma cells (in vitro) and improved cognitive behaviour that
related to memory ability (in vivo) [41].
Our findings illustrated the potential cellular signal-
ing pathways involved in aqueous extracts-stimulated
neuritogenesis, namely MEK/ERK1/2 and P13K/Akt
that are important in regulating growth and differenti-
ation of PC-12 cells. Specific inhibitors of MEK/ERK1/
2 and P13K/Akt could attenuate the ability of aqueous
extracts to stimulate neuritogenesis in PC-12 cells. The
MEK/ERK and PI3K/Akt signaling pathways can be ac-
tivated by NGF to stimulate neurite extension and
branching of neuronal cells [42-45]. Vaudry et al. [30]
reported that the activation of MEK/ERK signaling
pathway is necessary for neuritogenesis, in this case the
neuronal differentiation in PC-12 cells by NGF. Inhib-
ition of PI3K in PC-12 cells will avert NGF-stimulated
neurite elongation [25], promote cell protective effect
and cell survival [46].
In this study, the potentiation of aqueous extracts-
stimulated neuritogenesis was blocked by U0126, PD98059
and LY294002. Therefore, the MEK/ERK and PI3K/Akt-dependent signaling pathways play a crucial role in the
neuritogenic effect of medicinal mushrooms (Figure 5). This
is in agreement with a previous study by Phan et al. [16],
documented that MEK/ERK and PI3K/Akt signaling path-
ways were involved in neuritogenesis stimulated by extracts
of P. giganteus. Some studies have shown the involvement
of MAPK cascade in neuritogenesis. Extracts of Ganoderma
[18] and lysophosphatidylethanolamine, a neuroactive com-
pound isolated from G. frondosa [20] activated the MAPK
cascade through the MEK/ERK1/2 phosphorylation of PC-
12 cells.
Neurofilament staining by immunofluorescence served as
firm support to the observation that aqueous extracts-
stimulated neuritogenesis. Neurofilament is a neuron-
specific protein that serves as a major component of the
cytoskeleton that supporting the axon cytoplasm. It is a use-
ful indicator of PC-12 cell differentiation [21]. The images
showed clear morphological differences between the
inhibitor-treated and non-inhibitor-treated groups. The
addition of the MEK/ERK or PI3K/Akt inhibitors blocked
the neuritogenesis of PC-12 cells and the neurite outgrowth
of the NGF- and aqueous extracts-stimulated PC-12 cells.
Besides MEK/ERK1/2 and PI3K/Akt, other mecha-
nisms may still be addressed for a comprehensive under-
standing of neuritogenic activity. The interaction
between MEK/ERK and PI3K/Akt signaling pathways
determined by flow cytometry or immunoblot analysis
will be proposed for elucidation of mechanisms involved
in the neuritogenic activity of the three selected
mushrooms.
Conclusions
Our findings suggested that all the medicinal mush-
rooms tested possessed neuritogenic activity without
cytotoxic effect. The MEK/ERK1/2 and PI3K/Akt signal-
ing pathways may play a role in the neuritogenic activity
of the mushrooms. The precise mechanism underlying
this activity remains to be investigated.
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